ISOCIP isoprenaline hydrochloride 0.2 mg/1 mL injection solution ampoule

Land: Australien

Sprog: engelsk

Kilde: Department of Health (Therapeutic Goods Administration)

Aktiv bestanddel:

isoprenaline hydrochloride, Quantity: 200 microgram

Tilgængelig fra:

Cipla Australia Pty Ltd

Lægemiddelform:

Injection, solution

Sammensætning:

Excipient Ingredients: disodium edetate; sodium chloride; sodium citrate dihydrate; citric acid; hydrochloric acid; sodium hydroxide; water for injections

Indgivelsesvej:

Intracardial, Intramuscular, Intravenous Bolus, Intravenous Infusion, Subcutaneous

Enheder i pakken:

25 x 1 mL ampoules

Recept type:

(S4) Prescription Only Medicine

Terapeutiske indikationer:

ISOCIP is indicated: - for mild or transient episodes of heart block that do not require electric shock or pacemaker therapy. - for serious episodes of heart block and Adams-Stokes attacks (except when caused by ventricular tachycardia or fibrillation) (see section 4.3 Contraindications). - for use in cardiac arrest until electric shock or pacemaker therapy, the treatments of choice, are available (see section 4.3 Contraindications). - for brochospasm occurring during anaesthesia. - as an adjunct to fluid and electrolyte replacement therapy and the use of other drugs and procedures in the treatment of hypovolaemic and septic shock, low cardiac output (hypoperfusion) states, congestive heart failure and cariodgenic shock (see section 4.4 Special warnings and precautions for use).

Produkt oversigt:

Visual Identification: Clear colourless to practically colourless solution and no visible particulates; Container Type: Ampoule; Container Material: Glass; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Autorisation status:

Registered

Autorisation dato:

2022-03-24